Pre‑exposure Prophylaxis Awareness and Endorsement among Adolescents and Young Adults in Tanzania: Insights from the 2022 Demographic and Health Survey
- PMID: 39896105
- PMCID: PMC11784521
- DOI: 10.5334/aogh.4589
Pre‑exposure Prophylaxis Awareness and Endorsement among Adolescents and Young Adults in Tanzania: Insights from the 2022 Demographic and Health Survey
Abstract
Background: Pre‑exposure prophylaxis (PrEP) is an effective measure for preventing human immunodeficiency virus (HIV) infection among people at risk, including adolescents and young adults (AYA). Objectives: This study evaluates the prevalence of PrEP awareness and endorsement, as well as the factors associated with these outcomes, using data from the 2022 Tanzania Demographic and Health Survey. Methods: The analysis included participants aged 15-24 years. Participants were asked whether they had ever heard of daily medication to prevent HIV (PrEP) and whether they approved of daily PrEP use. Demographic characteristics and HIV testing information were also collected. Logistic regression models were used to assess factors associated with PrEP awareness and endorsement, and the weighted prevalence of these outcomes was calculated. Findings: A total of 8,268 respondents aged 15-24 years were evaluated, of whom 5,852 (70.9%) were female. Overall, the prevalence of PrEP awareness and endorsement was 6.9% (95% confidence interval [CI] 6.2-7.7) and 5.7% (95% CI 5.1-6.4), respectively. Female respondents (adjusted odds ratio [aOR] = 0.69; 95% CI 0.51-0.91) and rural residents (aOR = 0.78; 95% CI 0.61-1.00) had lower odds of PrEP awareness compared with male respondents and urban residents, respectively. Previously, HIV testing and receiving test results (aOR = 2.00; 95% CI 1.50-2.66) and an age of 20-24 years versus 15-19 years (aOR = 1.54; 95% CI 1.20-1.96) were associated with increased odds of PrEP awareness. The odds of AYA endorsement of PrEP were higher among those aged 20-24 years versus 15-19 years (aOR = 1.39; 95% CI 1.07-1.83) and those who previously tested for HIV and received results (aOR = 1.97; 95% CI 1.43-2.72), but lower among female respondents (aOR = 0.66; 95% CI 0.49-0.88). Conclusion: PrEP awareness and endorsement among AYA in Tanzania were low, with nearly 7 in 100 aware of PrEP and 6 in 100 approving of its use. Targeted interventions focused on adolescents, females, and rural communities are needed to increase PrEP awareness and usage to achieve the Joint United Nations Programme on HIV/Acquired Immune Deficiency Syndrome (AIDS) (UNAIDS) 95-95-95 goals for HIV epidemic control.
Keywords: PrEP awareness; PrEP use endorsement; Tanzania; adolescents and young adults.
Copyright: © 2025 The Author(s).
Conflict of interest statement
The authors have no competing interests to declare.
Similar articles
-
Knowledge and attitude to HIV pre exposure prophylaxis among women in five sub-Saharan African countries: a multilevel model analysis of population-based survey 2021-2022.BMC Public Health. 2024 May 7;24(1):1253. doi: 10.1186/s12889-024-18717-1. BMC Public Health. 2024. PMID: 38714974 Free PMC article.
-
Prevalence and determinants of HIV testing-seeking behaviors among women of reproductive age in Tanzania: analysis of the 2022 Demographic and health survey.AIDS Res Ther. 2025 Feb 6;22(1):14. doi: 10.1186/s12981-025-00710-2. AIDS Res Ther. 2025. PMID: 39915844 Free PMC article.
-
Low awareness and use of pre-exposure prophylaxis among adolescents and young adults in high HIV and sexual violence prevalence settings.Medicine (Baltimore). 2019 Oct;98(43):e17716. doi: 10.1097/MD.0000000000017716. Medicine (Baltimore). 2019. PMID: 31651904 Free PMC article.
-
HIV Preexposure Prophylaxis Among Adolescents in the US: A Review.JAMA Pediatr. 2020 Nov 1;174(11):1102-1108. doi: 10.1001/jamapediatrics.2020.0824. JAMA Pediatr. 2020. PMID: 32391878 Review.
-
HIV Pre-Exposure Prophylaxis Implementation Cascade Among Health Care Professionals in the United States: Implications from a Systematic Review and Meta-Analysis.AIDS Patient Care STDS. 2019 Dec;33(12):507-527. doi: 10.1089/apc.2019.0119. AIDS Patient Care STDS. 2019. PMID: 31821044 Free PMC article.
References
-
- UNAIDS. Global HIV & AIDS statistics—fact sheet. Accessed July 18, 2024. https://www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_....
-
- Tanzania HIV and Impact Survey. THIS 2022–2023. Accessed June 3, 2024. https://phia.icap.columbia.edu/wp-content/uploads/2023/12/THIS-SS_5DEC20....
-
- UNAIDS. End inequalities. End AIDS: Global AIDS Strategy 2021–2026. Accessed July 18, 2024. https://www.unaids.org/sites/default/files/media_asset/global-AIDS-strat....
-
- Ministry of Health. Tanzania National Guidelines for the Management of HIV and AIDS, 7th edition. Accessed August 13, 2024. https://hivpreventioncoalition.unaids.org/en/resources/tanzania-national....
-
- National AIDS Control Programme. Prevention of new HIV infection. Accessed August 13, 2024. https://nacp.go.tz/prevention-of-new-hiv-infection/.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous